211 results on '"Mirna, Moritz"'
Search Results
2. Early beta-blocker therapy improves in-hospital mortality of patients with non-ST-segment elevation myocardial infarction – a meta-analysis
3. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials
4. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
5. Novel Biomarkers as Potential Predictors of Decompensated Advanced Chronic Heart Failure—Single Center Study.
6. The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
7. Serum levels of C-terminal FGF23 (cFGF23) are associated with 1-year-mortality in patients undergoing transcatheter aortic valve replacement (TAVR)
8. Insulin-like Growth Factor-Binding Protein 2 in Severe Aortic Valve Stenosis and Pulmonary Hypertension: A Gender-Based Perspective.
9. Heat Shock Protein 70 Constitutes a Promising Novel Biomarker in Differential Diagnosis between Takotsubo Syndrome and Non-ST-Segment Elevation Myocardial Infarction.
10. Analysis of Novel Cardiovascular Biomarkers in Patients With Pulmonary Hypertension (PH)
11. Exercise-related T-wave oversensing: an underestimated cause of reduced exercise capacity in a pacemaker-dependent patient—a case report and review of the literature
12. Neutrophil-to-lymphocyte ratio and monocyte-to-lymphocyte ratio predict length of hospital stay in myocarditis
13. Reply to: “The beneficial effects of beta-blocker in patients with myocardial infarction: What are the underlying mechanisms?”
14. Correction to: The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
15. MicroRNA-30d-5p—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction
16. MicroRNA-30d—A Potential New Therapeutic Target for Prevention of Ischemic Cardiomyopathy after Myocardial Infarction
17. Missed Opportunities in Implementation and Optimization of Lipid-Lowering Therapies in Very-High-Risk Patients Presenting with ST-Segment Elevation Myocardial Infarction
18. Exposure to acute normobaric hypoxia results in adaptions of both the macro- and microcirculatory system
19. Reply to: “The beneficial effects of beta-blocker in patients with myocardial infarction: What are the underlying mechanisms?”
20. Clinical implications of fetuin-A
21. Prophylactic rivaroxaban in the early post-discharge period reduces the rates of hospitalization for atrial fibrillation and incidence of sudden cardiac death during long-term follow-up in hospitalized COVID-19 survivors
22. SERUM BIOMARKERS HS-TNI AND SST-2 PREDICT LONG-TERM RISK FOR CARDIOVASCULAR EVENTS IN DISCHARGED HOSPITALIZED COVID-19 SURVIVORS
23. Tei Index Complements Conventional Echocardiographic Parameters in Diagnostic Workup of Suspected Takotsubo Syndrome
24. Cell-Free Double-Stranded DNA to DNase Ratio Predicts Outcome after Primary Survived Cardiac Arrest
25. Diverging Concentrations of Soluble Suppression of Tumorigenicity (sST2) Analyzed by two Different Assays - a Limitation for its use in Clinical Practice?
26. Tei Index Is a Useful Adjunctive Tool in the Diagnostic Workup of Patients with Acute Myocarditis
27. Early antithrombotic post-discharge therapy using prophylactic DOAC or dipyridamole improves long-term survival and cardiovascular outcomes in hospitalized COVID-19 survivors
28. How spaceflight challenges human cardiovascular health
29. Biomarkers of Atrial Fibrillation Recurrence in Patients with Paroxysmal or Persistent Atrial Fibrillation Following External Direct Current Electrical Cardioversion.
30. A Novel Clinical Score for Differential Diagnosis Between Acute Myocarditis and Acute Coronary Syndrome – The SAlzburg MYocarditis (SAMY) Score
31. How Do Cardiovascular Biomarkers Behave in Patients with Severe Aortic Valve Stenosis with and without Echocardiographically Proven Pulmonary Hypertension?—A Retrospective Study of Biomarker Trends before and after Transcatheter Aortic Valve Replacement
32. Differences of Hemogram Parameters and Their Ratios among Patients with Takotsubo Syndrome, Acute Coronary Syndrome and Healthy Individuals
33. Comparison of PCWP and LVEDP Measurements in Patients with Severe Aortic Stenosis Undergoing TAVI—Same Same but Different?
34. From Streptococcal Pharyngitis/Tonsillitis to Myocarditis: A Systematic Review
35. Differential Diagnosis between Takotsubo Syndrome and Acute Coronary Syndrome—A Prospective Analysis of Novel Cardiovascular Biomarkers for a More Selective Triage
36. Gender-Specific Differences in the Intensive Care Treatment of COVID-19 Patients
37. Safety of the oral factor XIa inhibitor asundexian compared with apixaban in patients with atrial fibrillation (PACIFIC-AF): a multicentre, randomised, double-blind, double-dummy, dose-finding phase 2 study
38. Soluble ST2 as a Potential Biomarker for Risk Assessment of Pulmonary Hypertension in Patients Undergoing TAVR?
39. Pretreatment with Betablockers, a Potential Predictor of Adverse Cardiovascular Events in Takotsubo Syndrome
40. How spaceflight challenges human cardiovascular health
41. Dexamethasone Improves Cardiovascular Outcomes in Critically Ill COVID-19, a Real World Scenario Multicenter Analysis
42. A Comparative Analysis of Novel Biomarkers in Sepsis and Cardiovascular Disease
43. Treatment with Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Does Not Affect Outcome in Patients with Acute Myocarditis or Myopericarditis
44. Tei Index Complements Conventional Echocardiographic Parameters in Diagnostic Workup of Suspected Takotsubo Syndrome.
45. Correction to: The differential diagnostic value of selected cardiovascular biomarkers in Takotsubo syndrome
46. sST2 Predicts Short Term Therapy Success in Patients with Therapy Resistant Hypertension after Renal Sympathetic Denervation
47. Higher Incidence of Stroke in Severe COVID-19 Is Not Associated With a Higher Burden of Arrhythmias: Comparison With Other Types of Severe Pneumonia
48. Biological Sex and Its Impact on Clinical Characteristics in Patients Presenting with Myocarditis
49. Time to abandon ampicillin plus gentamicin in favour of ampicillin plus ceftriaxone in Enterococcus faecalis infective endocarditis? A meta-analysis of comparative trials
50. Analysis of Selected Cardiovascular Biomarkers in Takotsubo Cardiomyopathy and the Most Frequent Cardiomyopathies
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.